Table 5 Scale of public R&D investment in three subsectors (10,000 CNY)
From: Public funding and private investment for R&D: a survey in China’s pharmaceutical industry
2000 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | |
|---|---|---|---|---|---|---|---|---|
Chemical Medicine | 7,263 (8.77 million USD) | 17,216 (21.3 million USD) | 21,644 (27.63 million USD) | 27,454 (37.03 million USD) | 36,415 (53.16 million USD) | 38,947 (57.04 million USD) | 51,276 (77.42 million USD) | 68,693 (109.04 million USD) |
TCM | 3,235 (3.91 million USD) | 10,436 (12.92 million USD) | 10,650 (13.6 million USD) | 17,758 (23.95 million USD) | 21,764 (31.77 million USD) | 22,780 (33.36 million USD) | 16,824 (25.4 million USD) | 27,218 (43.2 million USD) |
Biopharmaceutical | 1,318 (1.59 million USD) | 4,789 (5.93 million USD) | 4,418 (5.64 million USD) | 7,127 (9.61 million USD) | 7,572 (11.05 million USD) | 14,551 (21.31 million USD) | 16,840 (25.43 million USD) | 17,322 (27.5 million USD) |